Speaker illustration

Doctor Julia Schoelermann

35Pharma Inc., Montreal (Canada)

Member of:

European Society of Cardiology

HS135, a novel activin and GDF trap, is highly efficacious in preclinical models of pulmonary hypertension and obesity-associated heart failure with preserved ejection fraction

Event: ESC Congress 2023

Topic: Vascular Diseases

Session: Therapeutic strategies to combat vascular disease

Thumbnail

ESC 365 is supported by